Brain stimulator and levodopa infusion impact on quality of life and functioning of the autonomic nervous system in Parkinson's disease patients [Aivo stimulaattorin ja levodopa infuusion vaikutus elämänlaatuun ja autonomisen hermoston toimintaan Parkinsonin tautia sairastavilla potilailla].

Trial Profile

Brain stimulator and levodopa infusion impact on quality of life and functioning of the autonomic nervous system in Parkinson's disease patients [Aivo stimulaattorin ja levodopa infuusion vaikutus elämänlaatuun ja autonomisen hermoston toimintaan Parkinsonin tautia sairastavilla potilailla].

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Sep 2014

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2014 Status changed from recruiting to completed, as per European Clinical Trials Database record.
    • 29 Mar 2012 Planned End Date changed to 10 Sep 2014.
    • 18 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top